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LipodystrophyThe obesity epidemic has intensiﬁed efforts to understand the mechanisms controlling adipose tissue devel-
opment. Adipose tissue is generally classiﬁed as white adipose tissue (WAT), the major energy storing tissue,
or brown adipose tissue (BAT), which mediates non-shivering thermogenesis. It is hypothesized that brite
adipocytes (brown in white) may represent a third adipocyte class. The recent realization that brown fat
exist in adult humans suggests increasing brown fat energy expenditure could be a therapeutic strategy to
combat obesity. To understand adipose tissue development, several groups are tracing the origins of mature
adipocytes back to their adult precursor and embryonic ancestors. From these studies emerged a model that
brown adipocytes originate from a precursor shared with skeletal muscle that expresses Myf5-Cre, while all
white adipocytes originate from a Myf5-negative precursors. While this provided a rational explanation to
why BAT is more metabolically favorable than WAT, recent work indicates the situation is more complex
because subsets of white adipocytes also arise from Myf5-Cre expressing precursors. Lineage tracing studies
further suggest that the vasculature may provide a niche supporting both brown and white adipocyte pro-
genitors; however, the identity of the adipocyte progenitor cell is under debate. Differences in origin between
adipocytes could explain metabolic heterogeneity between depots and/or inﬂuence body fat patterning par-
ticularly in lipodystrophy disorders. Here, we discuss recent insights into adipose tissue origins highlighting
lineage-tracing studies in mice, how variations in metabolism or signaling between lineages could affect body
fat distribution, and the questions that remain unresolved. This article is part of a Special Issue entitled:
Modulation of Adipose Tissue in Health and Disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction:
Obesity is a risk factor formanydiseases including type2diabetes, car-
diovascular disease, and cancer. Obesity occurs when energy intake ex-
ceeds energy expenditure causing adipose tissue to overgrow. However,
body fat distribution patterns are highly variable between individuals
and not all fat is equalwith somedepots havingmore favorablemetabolic
properties than others [1]. Some lipodystrophies also present as fat distri-
bution disorders characterized by regional lipoatrophy with other depots
being spared or even expanding [2,3].With aworldwide obesity epidemic
well underway, the study of adipose tissue growth, distribution, and reg-
ulation is a major research focus. Yet the developmental origins of fat, the
determinants of body fat distribution, and the signalingmechanisms that
control fat growth remain poorly deﬁned.2. Adipose tissue is complex and heterogeneous
In mammals, fat is typically classiﬁed by morphological appear-
ance as being either white adipose tissue (WAT) or brown adiposeion of Adipose Tissue in Health
Guertin).
l rights reserved.tissue (BAT). WAT (the primary site of energy storage) is mostly com-
posed of adipocytes containing a large unilocular lipid droplet. WATs
are found throughout the body; however, the distribution of mass
between each depot varies in the population as a function of
genetics, age, and for some depots, sensitivity to hormones and gluco-
corticoids. WAT location is often classiﬁed as being visceral (in the
trunk cavity) or subcutaneous (below the skin). There is not a uni-
formly applied system for describing the anatomical location of each
WAT depot and therefore depot names often vary between studies.
According to [4],WAT depots in rodents include the anterior subcutane-
ous WATs (asWATs) including interscapular and axillary WAT (located
in the scapular region), inguinalWAT (ingWAT; attached dorsally along
the pelvis to the thigh of the hindlimb), perigonadal WAT (pgWAT;
surrounding the uterus and ovaries in females and the epididymis
and testes in males), retroperitoneal WAT (rWAT; located within the
abdominal cavity along the dorsal wall of the abdomen behind the kid-
ney but not attached to the kidney ormixedwith perirenal brown fat),
and mesenteric WAT (mWAT; lining the surface of the intestines)
(Fig. 1). Although the primary function of WAT is energy storage, it
also functions as an endocrine organ secreting hormones and cyto-
kines such as leptin and adiponectin that regulate feeding and metab-
olism [5]. Epidemiological studies have found that the accumulation of
visceral fat (determined by high waist-to-hip ratio) associates with
metabolic disease (i.e. insulin resistance, type 2 diabetes, dyslipidemia,
Fig. 1. The Myf5 lineage contribution to the precursor pool in each fat depot varies with
its anatomical location. The contribution of the Myf5 lineage to the adipocyte precursor
cell compartment (deﬁned as CD31−CD45−Terr119−CD29+CD34+Sca1+ cells) was
recently determined by lineage tracing with Myf5-Cre;R26R-YFP mice. More than 95%
of the precursors in brown fat are labeled with Myf5-Cre. In the anterior subcutaneous
WATs (including interscapular and axial WATs) nearly 50% of the precursors trace to
Myf5+ precursors, and in the rWAT (a visceral WAT), the Myf5 precursors give rise to
approximately 70% of the adipocyte precursor cell pool. In contrast, the Myf5 lineage
contributes very little to the adipocyte precursor pool in ingWAT and pgWAT, which are
90–95% Myf5neg. The contribution of the Myf5 lineage to the intramuscular adipogenic
precursor pool (deﬁned with slightly different cell surface markers) is very low. Dotted
line indicates the abdominal cavity. References provided in the text.
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accumulation of subcutaneous WAT associates with improved insulin
sensitivity and low risk for developing type 2 diabetes [6–14].
Brown adipocytes contain multiple smaller (multilocular) lipid
droplets, are rich in mitochondria, and reside in depots that are highly
innervated and vascularized. In rodents, BAT is located in discrete
depots in interscapular (iBAT), sub-scapular (sBAT), and cervical (cBAT)
regions of the upper anterior side of the trunk and neck (Fig. 1) [4]. BAT
also grows around parts of the aorta and kidneys [15]. These depots
are often called “classical” BAT to distinguish them from brown-
adipocyte-like cells, called brite adipocytes, which reside within some
WATs (discussed below). In contrast to energy storing white adipocytes,
brown adipocytes are specialized to expend energy to generate heat in a
process called adaptive thermogenesis [16]. BAT is stimulated by the
sympathetic nervous system following exposure to cold temperature
and regulates the acute non-shivering thermogenesis response as well
as the adaptive cold acclimatization response following chronic cold
exposure. Thermogenesis is meditated by uncoupling protein 1 (UCP1),
which embeds in the inner mitochondrial membrane, and produces
heat by dissipating the proton electrochemical gradient over the inter-
mitochondrial membrane space without generating ATP [17]. BAT stores
energy for thermogenesis as perilipin coated lipid droplets and glycogen
granules [18,19] and upon stimulation rapidly increases glucose and
FA uptake to replenish its supplies. The high glucose uptake capacity of
BATmakes it readily detectable by 18F-ﬂuorodeoxyglucose positron emis-
sion tomography (FDG–PET) [17,20,21]. While long thought to be critical
only in rodents and newborn humans, the recent realization that BAT
functions in adult humans (made possible by its sensitivity to FDG–PET)
[22–26] raises the possibility that therapeutically controlling BAT growth
and/or energy expenditure could be a strategy to combat obesity [27–34].
Interest is also growing in a third potential class of adipocyte called
a brite adipocyte (also known as a “beige”, “inducible brown”, or
“recruitable brown” adipocyte) [19,21,35–41]. This mysterious type of
adipocyte exists among classical white adipocytes and is morphologi-
cally indistinguishable from its neighboring white adipocytes in the
basal or unstimulated state. However, upon stimulation by chronic
cold exposure (or other mechanisms that mimic beta-adrenergicstimulation) they become multilocular and begin expressing UCP1
[19,21,40,42]. The presence of brite adipocytes in the WAT of mice is
not homogeneous. For example, many adipocytes in ingWAT or rWAT
becomemultilocular and induce UCP1 following stimulation; however,
only a few UCP1+ brite adipocytes arise in pgWAT in the same mice
[19,40]. Brite adipocyte content varies between mouse strains and cor-
relates with overall strain sensitivity to high fat diet [43–47]. Whether
brite adipocytes form by trans-differentiation of existing white adipo-
cytes or arise from a unique preadipocyte lineage is under debate
(discussed below) [19,40,41,48–51]. Perhaps the biggest unresolved
issue pertaining to brite adipocytes is whether these cells actually con-
tribute signiﬁcantly to thermogenesis. For example, while UCP1mRNA
is induced in brite adipocytes several hundred-fold relative to white
adipocytes (which barely expresses UCP1) [38,52,53], the total UCP1
expression is still an order of magnitude lower than that detected in
brown adipose tissue [52]. In fact, the maximum thermogenic capacity
of brite fat has been estimated at only ~10% of classical brown fat in
mice. A debate is underway as to whether human brown fat is more
similar to brite fat or to classical brown fat in mice. Early reports argue
that what is currently being called human brown fat is more similar to
murine brite fat than to classical murine brown fat [48,49]. However,
recent studies that more extensively proﬁle different layers of adipose
tissue in newborns and adults reveals that humans have brown fat
deposits—particularly in the neck—that have a classic brown fat signa-
ture [54,55]. Interestingly, there appears to be a gradient of fat cell
types in the neck, with deep neck fat being classical BAT, intermediate
cells possibly beingmore brite-like, and themost peripheral adipocytes
being classical white adipocytes [55]. These ﬁndings are important
considering the growing emphasis on developing therapeutic strategies
to induce the “browning” of WAT in humans [35,56–59] because they
suggest that the studies of classical brown fat in mice could also have
important therapeutic implications in humans. The physiological signif-
icance and regulatory mechanisms of brown versus brite fat in humans
clearly need to be determined.
Each individual fat depot is complex, composed not only of mature
adipocytes but also of adipocyte precursor cells, ﬁbroblasts, nerves,
vascular cells, macrophages, and other cell types (collectively called
the stromal vascular fraction or SVF). Adding to their complexity is
the fact that adipose tissues are functionally heterogeneous. Although
the sharpest functional divergence is clearly between energy storing
WAT and energy-expending BAT, functional divergence is also evi-
dent between WATs best exempliﬁed by the risk associated with
excess visceral fat versus subcutaneous fat. However, such simple
distinctions are oversimpliﬁcations because differences in lipogenic
activity, cell dynamics, proliferative and differentiation capacity, and
gene expression even between categorically similar WAT depots
have been reported [60–67]. Heterogeneity likely exists even within
a single WAT as suggested by studies showing that neighboring
adipocytes can respond differently to genetic perturbations or drugs
[68–72]. The existence of such heterogeneity within and between fat
tissues suggests broad conclusions should not be based on a limited
survey of select fat depots, and that each depot should be considered
separately.
Does adipocyte tissue heterogeneity reﬂect different developmen-
tal origins of adipocytes, variances in the developmental cues a partic-
ular adipocyte may experience during differentiation, or extracellular
inﬂuences on the mature adipocytes unique to the local cell or tissue
environment? Answering these questions could lead to new anti-
obesity therapies, improve the understanding of lipodystrophies, and
increase the prospect of using adipocyte progenitor cells for cell-based
therapeutics [17,73,74].
3. The origin of adipocytes
Central to understanding the complexities and heterogeneity
of adipose tissue is to understand where the path to becoming an
Table 1
Summary of recent lineage tracing studies of pre- and mature adipocytes.
Genetic approach Promoter
location
Rationale Reported result References
White adipocytes sox10-Cre;R26R-eYFP Transgene Sox10 expresses in pre- and migratory neural
crest cells at all rostro-caudal levels
Mature adipocytes in the salivary gland labeled




Knock-in PPARγ is a nuclear receptor expressed in all
tissues and is critical for adipogenesis
ingWAT and rWAT positive; some positive SVF
cells
[82]
aP2-GFP Transgene aP2 (FABP4) expresses in mature adipocytes
and is a target of PPARγ
ingWAT positive [82]
aP2-Cre;R26R-LacZ Transgene Described above ingWAT and pgWAT positive [82]
PDGFRβ-Cre;
R26R-LacZ
Transgene PDFGRβ is expressed in vascular mural cells ingWAT and rWAT positive [82,140]
myf5-Cre;R26R-eYFP Knock-in Myf5 is a muscle differentiation transcription
factor that is ﬁrst expressed in the
dermomyotome at E8.0 and expresses in adult
satellite cells
ingWAT and pgWAT negative [116,117]
wnt1-Cre;R26R-eYFP Transgene Restrictive marker of migrating neural crest
cells
Cephalic WAT positive; pgWAT and ingWAT
negative. 70% of adipocyte precursors in cephalic
WAT positive; all ingWAT adipocyte precursors
negative
[104,141]
LysM-Cre;R26R-LacZ Knock-in The lysozyme M is exclusively expressed in
macrophages and granulocytes
5–20% of pgWAT adipocytes positive [110,111]
VE-cadherin-Cre;
R26R-LacZ
Knock-in VE-cadherin is expressed in endothelial cells, is
involved in cell adhesion, and is essential for
vascular system development
ingWAT and pgWAT positive [96,98]
VE-cadherin-Cre;
R26R-eGFP





Knock-in VE-cadherin-CreERT2 is a tamoxifen-inducible
version of the VE-cadherin-Cre
Numerous adipocytes in the ingWAT, pgWAT
and BAT positive
[97,98]
ZFP423-GFP Knock-in Zfp423 is a transcriptional regulator broadly





Knock-in Pax3 is a muscle differentiation transcription
factor ﬁrst expressed in dorsal neural crest and
somites; it cooperates with Myf5 to drive
muscle development
50% of the adipogenic SVF cells from asWAT
positive
[123,124]
myf5-Cre;R26R-LacZ Knock-in Described above Mature adipocytes from asWAT and rWAT
positive; few mature adipocytes from ingWAT
and pgWAT positive; 50–60% of adipogenic SVF
cells from asWAT and rWAT positive; b2% from
the ingWAT and pgWAT positive
[83,117]
myf5-Cre;R26R-eYFP Knock-in Described above 50–70% of the adipocyte precursors from asWAT
and rWAT positive; b10% of the adipocyte




Knock-in Vav1 is a proto-oncogene that expresses in the
hematopoietic and lymphoid systems
All adipocyte precursors and mature adipocytes
from ingWAT, pgWAT, rWAT andmWATnegative
[100,112]
tie2-Cre;R26R-mTmG Transgene Tie2 is an angiopoietin receptor speciﬁc to
endothelial cells and some hematopoietic cells
All adipocyte precursors and mature adipocytes




Knock-in Described above All adipocyte precursors and mature adipocytes




Transgene PDGFRα is expressed in most mesenchymal
cells can activate the MAPK, PI3K and PLCγ
signaling pathways
All adipocyte precursors and mature adipocytes
from ingWAT, pgWAT, rWAT and mWAT
positive
[100,143]
Brown adipocytes En1-Cre;R26R-LacZ Knock-in Engrailed 1 is a homeobox transcription factor
that expresses in cells of the central
dermomyotome
BAT positive [114,144]
myf5-Cre;R26R-eYFP Knock-in Described above BAT positive [116,117]
pax7-CreERT2;
R26R-LacZ
Knock-in Pax7 is expressed in medial and central cells of
the dermomyotome and in adult satellite cells
BAT positive [121,122]
myf5-Cre;R26R-LacZ Knock-in Described above BAT positive; >99% of adipogenic BAT SVF cells
positive
[83,117]
myf5-Cre;R26R-eYFP Knock-in Described above >95% of BAT adipocyte precursors positive [83,117]
VE-cadherin-Cre;
R26R-LacZ
Knock-in Described above BAT positive [96,98]
VE-cadherin-CreERT2;
R26R-LacZ
Knock-in Described above Many brown adipocytes positive [97,98]
Brite adipocytes myf5-Cre;R26R-eYFP Knock-in Described above Brite adipocytes in ingWAT negative [116,117]
myf5-Cre;R26R-LacZ Knock-in Described above CL316,243 induced brite adipocytes in asWAT










Knock-in UCP1 is the most accepted functional marker of
brown adipocytes
Brite and white adipocytes interconvert in
ingWAT depending on the temperature
[51]




Rationale Reported result References
Adipocyte precursors in
skeletal muscle
myf5-Cre;R26R-eYFP Knock-in Described above Negative [84,117]
myf5-Cre;R26R-eYFP Knock-in Described above Negative [37,117]
myf5-Cre;
R26R-mTmG
Knock-in Described above Negative [117,124]
Pax3-Cre;
R26R-mTmG
Knock-in Described above Negative [123,124]
R26R: Rosa 26 reporter.
tTA: tetracycline transactivator.
TRE: tetracycline response element.
SVF: stromal vascular fraction.
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could be useful in ﬁghting obesity; however the identity of the adipo-
cyte progenitor cells is just beginning to be unraveled. As obesity
progresses, adipose tissues grow by hypertrophy (increasing the size
of their adipocytes) and by hyperplasia (increasing the number of
adipocytes) [75–79]. A yearly adipocyte turnover rate for lean and
obese humans of 10% has been reported [79], but because mature
adipocytes do not divide, a resident adipocyte precursor cell must exist.
Undifferentiated adipocyte progenitor cells were long assumed
to reside in the stromal vascular fraction, but only recently have cell
surface markers been used to distinguish adipocyte precursor cells
fromnon-adipogenic stromal cells byﬂuorescence activated cell sorting
(FACS) [37,80–82]. One study identiﬁes a CD45−CD31−Ter119−(Lin−)
CD29+Sca1+CD34+CD24+ population that contains adipocyte progen-
itors capable of reconstituting a functional white adipose tissue when
transplanted into lipodystrophic mice [80]. Similar cell surface markers
have been used to isolate adipocyte precursors frombrown fat and skel-
etal muscle [37,83,84]. Whether prospectively isolated adipocyte pre-
cursors originating from different fat depots are functionally similar is
an open question. Moreover, whether a true adipocyte stem cell exists
that can serially reconstitute an entire fat tissue including the same
complement of stemand committed progenitor cells is unclear. Notably,
depot-speciﬁc differences have been reported in adipocyte precursor
cell surface marker expression levels, gene expression proﬁles, pro-
liferation and differentiation capacity, and response to high fat diet
[81,85–87]. Strain-dependent differences in adipocyte precursor cell
number have also been observed [85]. It has been argued that using
cell surface markers to isolate adipose precursors is problematic
because these markers lack functional relevance and cannot be used
to localize adipocytes in vivo [88]. While valid, alternative approaches
rely on identifying adipocyte precursor cell functional marker genes
and using the promoter to drive expression of a reporter to genetically
mark lineages (to date, a truly speciﬁc adipocyte precursor cell func-
tional marker remains elusive) [21,89,90]. Both approaches are in
fact quite complimentary; however, in clinical practice the most
practical method to isolate adipocyte precursor cells from human
lipoaspirates is by cell sorting based on surfacemarker expression [73].
Protocols to prospectively isolate human adipocyte precursor cells are
currently being optimized.
Lineage tracing on the other hand is the only technique that can
conclusively indicate the developmental origin of an adipocyte or
reveal which tissue-resident progenitors actually become mature
adipocytes, and therefore these studies can only be performed in mice.
Many groups are performing lineage-tracing analyses using transgenic
and Cre–Lox technology [Table 1]. Hypothesizing that peroxisome
proliferator-activated receptor γ (PPARγ) expression is an early marker
of adipocyte commitment, one study marked PPARγ-expressing stromal
vascular fraction cellswithGFP (using aPPARγ-tetracycline transactivator
(tTA) knock-in mouse together with the tetracycline response element
(TRE)-H2B-GFP reporter system) [82]. This labeled an adipocyte precur-
sor population that expresses cell surface markers that are similar to the
prospectively isolated adipocyte precursors described above suggesting
that early precursors express PPARγ [80]. Interestingly, these GFPmarkedprecursors appear to commit to the adipocyte lineage in embryonic devel-
opment or shortly after birth, and localize in vivo to the adipose tissue
mural cell compartment of the vasculature [82]. Using platelet-derived
growth factor receptor β (PDGFRβ) expression (which marks mural
cells in many tissues) to isolate and fractionate stromal vascular fraction
cells conﬁrmed that the PDGFRβ+ mural cells in adipose tissue, but not
in other tissues like the kidneys, skeletal muscle, and cardiac muscle, are
enriched for adipogenic precursors. In fact, when PDGFRβ-Cre is com-
bined with the Rosa 26 reporter (R26R)-LacZ reporter (which perma-
nently labels PDGFRβ-Cre expressing cells and their descendants)
rWAT and ingWAT are homogeneously marked [82]. The PDGF recep-
tors (PDGFRα and β) are platelet-derived growth factor sensing recep-
tor tyrosine kinases that activate several down-stream signaling
pathways including the MAPK, PI3K and PLCγ pathways [91]. In con-
trast, PPARγ-GFP lineage tracing only labels a subset ofmural cells, indi-
cating that while all the adipocytes appear to arise from mural cells,
only a subset of the mural cells are adipogenic [82]. What determines
the identity of the adipogenic population is not known. These observa-
tions are consistent with previous ultra-structural ﬁndings suggesting
the adipose vasculature may function as the adipocyte progenitor cell
niche [92–94].
The theory that adipocytes arise from a vascular bed has recently
been expanded to include the hypothesis that adipocytes actually
originate from a subset of endothelial cells. For example, transgenic
mice driving GFP expression from the promoter of the zinc ﬁnger pro-
tein 423 (zfp423), a transcription factor involved early in preadipocyte
commitment, not only labels mural cells, but also some endothelial
cells in ingWAT and iBAT as determined by co-expression with the
endothelial cell marker CD31 and PDGFRβ [88,95]. Interestingly, the
zfp423-GFP marked cells are different from those marked with
PPARγ-GFP, and exhibit depot-speciﬁc differences in the expression of
surface markers [80,82,95]. Thus, zfp423 could be a functional marker
of white and brown preadipocytes early in commitment. However,
the speciﬁcity of zfp423 to preadipocytes is unclear because it is also
expressed in skeletal muscle and brain tissues at comparable levels
[95]. A related study also arrives at an endothelial-cell-of-origin model
using the endothelial cell speciﬁc VE-cadherin-Cre knock-in allele
with the R26R-LacZ reporter, which reportedly marks adipocytes in
pgWAT, ingWAT and iBAT [96–98]. However, another study found
that conditionally deleting PPARγwith the endothelial speciﬁc receptor
tyrosine kinase-Cre (Tie2-Cre) did not affect PPARγ expression in fat
or adipose tissue mass [99]. Moreover, when the same constitutive
VE-cadherin-Cre driver or Tie2-Cre is used in combination with the
R26R-mTmG reporter (in which Cre turns off expression of membrane-
targeted Tomato ﬂuorescent protein and induces expression of
membrane-targeted GFP) no adipocytes expressed GFP indicating that
VE-cadherin or Tie2 was not expressed in their lineage [100]. These con-
tradictory ﬁndings might suggest that only subsets of adipocytes are of
endothelial cell origin. This needs further investigation.
Accurate lineage tracing can be challenging in adipocytes and this
warrants a brief discussion of certain considerations. For starters,
in any lineage tracing study drivers expressed from an endogenous
locus/promoter are preferred because they more likely reﬂect the
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when tracing mature adipocytes is their paucity of cytoplasm. This
poses a particular problem when analyzing tissue sections for the
expression of cytoplasmic reporters, such as LacZ or YFP/GFP. The
mTmG reporter overcomes this caveat because theﬂuorescent reporters
are membrane targeted and therefore concentrate the reporter at the
cell membrane surrounding the predominantly lipid-ﬁlled interior of
the adipocyte. It is also wise to employ careful co-staining with known
markers to distinguish between signals emanating from the miniscule
membrane/cytoplasmic region of the adipocyte from signals originating
in the abutting stromal vascular fraction cells, especially in highly
vascularized depots.
While progress is being made in identifying the white adipocyte
progenitors residing in mature adipose tissues, much less is under-
stood about the embryonic origins of these progenitors. Previously
all adipocytes were thought to arise from a commonmesodermal pre-
cursor [17], but in recent years lineage tracing studies appear to have
challenged this assumption and the emerging view—perhaps not sur-
prisingly—is that white adipocyte ancestry is complex. An early clue
suggesting white adipocytes might have different ancestries comes
from the pathology of certain partial lipodystrophies. For example
patients with familial partial lipodystrophy type 2 (FPLD2; OMIM
#151660 — also called Dunnigan syndrome) suffer from the gradual
atrophy of adipose tissue in the limbs and parts of the trunk while
adipose tissue in the face, neck, and intra-abdominal areas are spared
and often increase in mass. Similarly, in congenital inﬁltrating
lipomatosis of the face (CIL-F) excessive adipose tissue only inﬁltrates
the facial soft tissue forming a lipomatous tumor that causes severe
disﬁgurement [101,102]. Such regional characteristics suggest a dis-
tinct adipogenic route in the cephalic region. Consistent with this
hypothesis, lineage-tracing studies in mice indicate that Sox10-Cre,
which expresses in pre-migratory and migratory cells of neural
crest, mark adipocytes in the head but not in the ingWAT and pgWAT
[103]. A related lineage tracing study using the Wnt1-Cre, which is in-
duced during neural crest formation, ﬁnds that craniofacial progenitors
and adipocytes but not subcutaneous or visceral adipocytes trace to a
neural crest cell of origin [104]. This study also ﬁnds that the neural
crest adipogenic lineage is the predominant contributor to a pool of
adipogenic progenitors residing in both the cephalic fat and muscle.
Curiously, the number of neural crest-derived progenitors declines
with age and are replaced with an unidentiﬁed lineage in what has
been called a lineage-succession model [104]. Interestingly, these two
distinct adipogenic lineages have similar metabolic properties indicat-
ing that their divergent origin does not impart any unique functional
feature that distinguishes them. Bones and skeletal muscles in the head
are known to originate from the neural crest [105]. Thus, one possibility
is that some adipocytes could share a common origin with their neigh-
boring organs and this might reﬂect an important developmental
relationship.
It has been reported that some adipogenic cells originate in the
bone marrow, and that after bone marrow transplants in rodents,
hematopoietic cells become adipocytes in iBAT, asWAT, omental WAT,
and mWAT [106–108]. Moreover, it has also been reported that a sub-
stantial number of adipocytes in the pgWAT are labeled with lysozyme
2-Cre in LysM-Cre;R26R-LacZ mice in which Cre expression marks the
myeloid lineage [109–111]. However, this too is up for debate because
Vav1 oncogene-Cre (Vav1-Cre), which marks hematopoietic lineages
[112] fails to label any adipocytes or adipocyte progenitors [100].
4. The Myf5 lineage contribution to fat
While the vision of white adipocyte origins remains blurred, what
seemed to be increasing in clarity was that brown adipocytes arise
from a distinct mesenchymal precursor cell shared with skeletal
muscle, but not with any white adipocyte. Evidence suggesting that
BAT and WAT could have distinct developmental origins ﬁrst camefrom a lineage tracing analysis of central dermomyotome cells express-
ing the transcription factor Engrailed1 (a pattern formation related
Homeobox-family member) with an En1-CreER knock-in allele [113].
Using the R26R-LacZ reporter this study revealed that iBAT but not
ingWAT or pgWAT shares a common origin with skeletal muscle and
dermis [114] [Radhika Atit, personal communication]. Using micro-
arrays to compare the gene expression proﬁles of preadipocytes during
in vitro differentiation, a subsequent study determined that brown
preadipocytes isolated from a mix of iBAT, sBAT and cBAT but not
white preadipocytes from pgWAT have a myogenic-like transcriptional
signature (including expression of myogenic factor 5 (Myf5) and
myogenic differentiation antigen (MyoD)) [115]. This model seemed
all-but-conﬁrmed by a report that traced the Myf5 lineage in fat [116].
In this study, the Myf5-Cre knock-in allele [117] was used to drive YFP
expression from the R26R-YFP reporter. Using an anti-GFP antibody
to detect YFP by immunoﬂuorescence, it was shown that regionally
localized iBAT and skeletalmuscle, but not interscapularWAT expresses
YFP [116]. YFP was also not detected in the brite adipocytes induced to
form within ingWAT. This Myf5-Cre labeling pattern was conﬁrmed by
examining YFPmRNA expression. Other related work found that when
Myf5-Cre drives expression of the R26R-diphteria toxin A-chain con-
struct, the Myf5-lineage is ablated and this greatly reduces the classical
BAT depots [118,119] [Thomas Braun, personal communication]. Finally,
lineage tracing performed with Pax7 (paired box7)-Cre or Pax3 (paired
box3)-Cre knock-in alleles (Pax7 and Pax3 are transcription factors that
cooperatewithMyf5 to drivemyogenesis) also label BAT [120–124]. The
notion that BAT and skeletal muscle share a common origin distinct
from WAT is logical because of the metabolic similarities between BAT
and muscle (such as high mitochondrial content and increased energy
expenditure) and thus from these studies emerged a model arguing
that brown adipocytes can be delineated from white (and brite) adipo-
cytes by their ancestral expression of Myf5 [17,89].
The simplicity and logic behind theMyf5model led to its widespread
acceptance. Therefore, the recent ﬁnding that deleting phosphatase and
tensin homolog (PTEN) with Myf5-Cre affects brown and white adipose
tissuewas quite surprising [83]. PTEN is a tumor suppressor andnegative
regulator of the insulin-PI3K–AKT–mTOR growth pathway [125]. In a
genetic study aimed at understanding how this pathway regulates the
growth of mesodermal derived tissues, the same Myf5-Cre knock-in
allele used previously to trace the origin of brown adipocytes was used
to conditionally delete PTEN. Themyf5-cre;PTENﬂ/ﬂ conditional knockout
(PTENmyf5cKO) mice have severely overgrown interscapular, subscapular,
and cervical BATs that are PTEN-deﬁcient, consistent with brown adipo-
cytes originating from a Myf5-positive (Myf5+) lineage. However, in
contradiction to the model that all white adipocytes originate from a
Myf5-negative (Myf5neg) precursor, PTENmyf5cKO mice also have hyper-
trophic anterior subcutaneous WATs and retroperitoneal WAT that are
also PTEN deﬁcient [83]. Evenmore surprising is that pgWAT andmesen-
tericWAT aswell as posterior subcutaneousWATs including ingWAT are
completely absent [83] (Fig. 2). This total body fat redistribution pheno-
type led to a comprehensive reevaluation of theMyf5+ lineage contribu-
tion to fat.
Originally, the Myf5 lineage had only been examined in a few
adipose tissue depots. To revisit the Myf5+ lineage contribution to
adipose tissue, the Myf5-Cre knock-in allele [117] was again com-
bined with R26R-YFP reporter and separately with the R26R-LacZ
reporter, and lineage tracing was performed on a broad selection of
depots [83]. Here, Myf5-Cre was found to drive YFPmRNA expression
not only in classical brown fat depots (iBAT, sBAT and cBAT) as
expected, but also in anterior subcutaneous white fats (interscapular
and axillary) and in rWAT. In contrast, very little YFP mRNA expres-
sion was detected in white adipocytes located in the ingWAT or
pgWAT. These results were conﬁrmed using Myf5-Cre;R26R-LacZ
mice indicating that the Myf5-lineage contribution to fat is broader
than previously thought. As mentioned above, En1-CreER had previ-
ously been shown to label dorsal dermis in addition to skeletal muscle
Fig. 2. Deleting PTEN with Myf5-Cre models partial lipodystrophy. Deleting PTEN with Myf5-Cre causes lipohypertrophy of the fat depots largely derived from Myf5+ adipocyte
precursors (labeled in blue) and lipoatrophy of the fats that are largely Myf5neg (labeled in red). The overgrown fats are bigger because they contain more cells due to expansion
of the Myf5+ adipocyte precursor cell population (not shown) and bigger cells as a result of increased lipid content (see histology insets). The absent fats are reduced to ﬁbrotic
tissue. This body fat distribution phenotype resembles the pathology of a rare human lipodystrophy syndrome called Madelung's disease.
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Gurmaches & DA Guertin) and reportedly (using a different Myf5-Cre
knock-in allele) a portion of the ribs and cervical vertebrae [127].
Thus, it is perhaps not surprising that Myf5-Cre also labels white
adipocytes in the same general anatomical location.
Interestingly, when stromal vascular fraction cells are prepared
from various WAT depots isolated from Myf5-Cre;R26R-LacZ mice
and differentiated in vitro, about half of the adipogenic cells from
the asWATs or rWAT trace with Myf5-Cre compared to less-than 1%
in ingWAT and pgWAT. This mixed lineage contribution is also de-
tectable in the adipocyte precursor pool. Using Myf5-Cre;R26R-YFP
and a FACS-based cell sorting strategy based on [80], it was found
that most of the CD31−CD45−Ter119−CD29+Sca1+CD34+ cells iso-
lated from BAT, nearly half of the adipocyte precursors isolated from
the asWATs, and three-quarters of the adipocyte precursors isolated
from rWAT, trace with Myf5-Cre. In contrast, less than 10% of the
adipocyte precursors isolated from ingWAT and pgWAT are marked
(Fig. 1). Gene expression analysis indicates that the Myf5-Cre tracing
white adipocyte precursors do not express brown preadipocyte
markers [83]. Consistent with these data, a recent study ﬁnds that
the Pax3-Cre knock-in allele also labels adipogenic precursors isolated
from the stromal vascular fraction of asWAT [124]. Interestingly, the
Pax3-Cre driver also labels adipocyte precursor cells with a pattern
similar to the Myf5-Cre driver (J Sanchez-Gurmaches and DA Guertin,
unpublished). Why previous work failed to uncover the Myf5-lineage
contribution to white fat could reﬂect the limited survey of fat depots,
technical limitations, or strain differences.
5. A revised Myf5 lineage model and its implications
These new insights suggest a revised model of the Myf5-Cre lineage
contributions to adipose tissue. We propose two possibilities: In Model
(I) the Myf5+ (Pax3+) adipocyte precursors could originate in the cen-
tral dermomyotome and mix with Myf5neg (Pax3neg) lineage(s) in the
adipocyte precursor cell compartment of each depot (Fig. 3). In BAT,
most of the adipocyte precursors are Myf5+, in asWATs and rWAT the
mix is more evenly distributed, while in other WATs such as ingWAT
and pgWAT, a Myf5neg lineage(s) predominates (Fig. 1). Based on this
model, one might predict that the mature adipocyte pool in each depot
would reﬂect this heterogeneity. Interestingly however, Myf5-Cre line-
age tracing of mature adipocytes with the R26R-LacZ reporter reveals a
large fraction of the mature adipocytes in BAT, asWAT, and rWAT are
LacZ positive, while only a few (b1%) mature adipocytes in ingWAT
and pgWAT are positive [83]. Thus, despite the heterogeneity in theadipocyte precursor cell compartment, it appears that theMyf5+ lineage
may selectively differentiate in the BAT, asWATs, and rWAT, while
Myf5neg lineages selectively give rise to most adipocytes in the ingWAT
and pgWAT. Importantly, exactly what cell types are contained within
the adipocyte precursor pools as identiﬁed by cell surface markers, and
how selective expansion of certain lineages might be determined is not
known. Notably, the true adipocyte progenitor is likely contained within
a subset of the adipocyte progenitor cell pool and it cannot yet be ruled
out that Myf5neg precursors give rise to Myf5+ (Pax3+) precursors
within that pool. Accordingly in Model (II), Myf5-Cre (and Pax3-Cre)
expression could be induced during determination or adipocyte differen-
tiation in some depots (Fig. 3). Thus, it will be important to determine
exactly when Myf5-Cre and Pax3-Cre express in the adipocyte lineages
(e.g. with an inducible Cre), how many mature adipocytes in each
depot arise from these lineages, andwhetherMyf5/Pax3 have functional
roles in these adipocytes [128]. This requires further investigation.
Previously, it made sense that the mitochondria rich and energy
expending brown fat might share a common precursor with skeletal
muscle, but what is the signiﬁcance of arising from a Myf5+ (Pax3+)
versus a Myf5neg (Pax3neg) precursor for a white adipocyte? One possi-
bility is that progenitors and/or mature adipocytes arising from Myf5+
precursors could have a metabolic advantage (or disadvantage). Meta-
bolic variations between distinct lineages could affect depot-speciﬁc
fat growth and thus body fat patterning. Another possibility is that
endocrine function could vary between lineages. Alternatively, there
may be no functional differences between the adipocyte precursor
cells arising from Myf5 positive or negative precursors. Precedence for
such functional convergence exists. For example, it was recently shown
that dermal precursors in the trunk arise from Myf5+ precursors while
dermal precursors in the face arise from Myf5neg (Wnt1+) precursors,
yet despite having different developmental origins, the mature dermal
cells appear functionally similar based on marker proﬁle, proliferation
capacity, and ability to self-renew and differentiate [126]. Similarly,
adipogenic precursors that arise from theneural crest appear functionally
similar to mesoderm-derived adipogenic precursors [103,104]. Thus,
being of a different developmental origin does not automatically imply
a functional difference.
While it remains to be seen whether natural variations in metab-
olism between white adipocytes of different origins contributes to
body fat patterning, is it possible that a mutation could arise that
targets a speciﬁc adipocyte lineage. Such a mutation could alter the
growth, metabolism, or insulin sensitivity of that lineage, and it seems
reasonable to speculate that such a scenario could be the basis of certain
lipodystrophy disorders. Lipodystrophy can be inherited or more
Fig. 3. Where is Myf5-Cre expressed during adipocyte development? At least two models could explain the origins of adipocytes that trace to Myf5-Cre+ precursors. (I) In the
“common origin model”, Myf5+ (and possibly Pax3+) adipocyte precursors originate in the central dermomyotome during embryonic development and give rise to adipocyte pro-
genitor cells residing in the stromal vascular fraction of each depot. Both Myf5+ and Myf5neg lineages contribute to the adipocyte precursor cell pool (Lin−CD29+CD34+Sca1+) to
varying degrees in each depot; however in BATs, asWATs, and rWAT the Myf5+ lineage precursors appear to be preferentially selected to become adipocytes while in the ingWAT,
pgWAT, and mWAT the Myf5neg lineage precursors selectively differentiate. (II) Alternatively, in the “selective induction model”Myf5neg precursors residing in the stromal vascular
fraction of asWAT and rWAT (and perhaps even in BAT) induce Myf5-Cre (and possibly Pax3) expression upon differentiation giving rise to Myf5+ precursors, while in the other
WATs Myf5-Cre is not induced. Whether Myf5 protein has a functional role in these adipocyte lineages is unknown.
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lipoatrophy) or only speciﬁc regions (i.e. partial lipoatrophy). In many
cases of partial lipodystrophy the spared regions increase in mass for
example in Dunnigan-type familial partial lipodystrophy (described
above) and Barraquer–Simons partial lipodystrophy (in which
lipoatrophy begins in the head and neck and spreads to the chest, abdo-
men and upper extremities, while the adipose tissues in the lower
abdomen, gluteal region, and lower extremities expand) [129]. Even
in congenital generalized lipodystrophy or Berardinelli–Seip syndrome,
which is characterized by the near-complete absence of adipose tissue,
some fat depots are spared including those in the head, palms, and sole
of the foot [2]. These regional variations in fat pathology have contribut-
ed to the hypothesis that adipocytes have distinct developmental
origins.
Consistent with the idea that lineage-restricted mutations could
cause lipodystrophy is the discovery that PTEN loss in the Myf5 line-
age causes severe body fat redistribution [83]. In PTENmyf5cKO mice,
body fat is redistributed such that Myf5+ adipocytes expand (causing
lipohypertrophy of BAT, asWATs, and rWAT) at the expense of
Myf5neg adipocytes (i.e. inguinal, perigonadal, and mesenteric WAT),
which are reduced to ﬁbrotic tissue (Fig. 2). The hypertrophic fats
have more cells due to expansion of the adipogenic precursors, and
bigger cells caused by increased lipid content. PTENmyf5cKO mice also
exhibit skeletal muscle atrophy, which appears to be caused by a sys-
temic effect because PTEN expression is maintained at normal levels
in most skeletal muscles by a post-transcriptional mechanism. Losing
PTEN hyperactivates the major intracellular effectors of insulin includ-
ing PI3K, AKT, and mTOR, which likely alters the metabolic balance in
theMyf5 adipocyte lineage to favor energy uptake and storage. Interest-
ingly, the PTENmyf5cKO mouse phenotypically resembles a rare partial
lipodystrophy syndrome called multiple symmetric lipomatosis or
Madelung's disease [3]. Patients with Madelung's disease suffer from
mild to severe adipose tissue expansion in the head and neck with
extension down the back (type I) and/or the shoulders, upper arms
and abdomen (type II). The PTENmyf5cKO phenotype also resembles thebuffalo hump syndrome often seen in HIV patients on aggressive anti-
retroviral therapy, which is currently the most common lipodystrophy
disorder in the United States [130]. Thus, the PTENmyf5cKO mouse is a
novel model of partial lipodystrophy and its phenotype supports the
idea that mutations targeting metabolism or the metabolic regulatory
circuits in a particular adipocyte lineage could be the pathological
basis of certain lipodystrophies.
6. Where do brite adipocytes come from?
In response to cold or β-adrenergic agonists, brite adipocytes
appear within white fat and can comprise a signiﬁcant fraction of the
total adipocyte population depending upon the depot. While ingWAT
and to a lesser extent rWAT are predisposed to browning based on
their rapid response to acute cold challenge, other depots like pgWAT
are more resistant and only show some browning after chronic cold
challenge [4,21,41,52]. Two models have been proposed to explain the
origins of brite adipocytes. One posits that brite adipocytes arise by
transdifferentiation of existing mature white adipocytes; the second
argues that brite adipocytes arise de novo froma distinct precursor pop-
ulation [41,48,50,131]. These models may not be mutually exclusive
and depot-speciﬁc differences may exist (discussed below).
The brite adipocytes that arise in the largely Myf5neg lineage fats
(e.g. pgWAT and ingWAT) are reportedly Myf5neg while the brite
adipocytes arising in Myf5+ lineage fats (e.g. asWATs and rWAT)
are Myf5+ [83,116]. This is an important point because it is argued
that all brite adipocytes are Myf5neg, which is true in ingWAT but
not in rWAT or asWATs. Thus, brite adipocytes from different depots
likely have different origins. Factors like the proximity to noradrener-
gic parenchymal nerve ﬁbers, to the vasculature, or exposure to other
micro-environmental conditions could determine which cells become
brite [19,40,41]. Recently, several preadipocyte cell lineswere sub-cloned
from immortalized stromal cultures derived from ingWAT, and only
some of these lines responded like a brite preadipocyte (called beige in
this report) would be predicted too following stimulation (i.e. induce
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were found to express distinct surface markers, lineage tracing was not
performed, thus it is unclear if they represent a unique brite-adipocyte
lineage. Brite/beige adipocytes from other white fat tissues were not
examined [48].
Interestingly, another study ﬁnds that when mice are treated with
a low dose of the β3-agonist CL316,243 that promotes proliferation
but avoids inﬂammation, the brite adipocytes appearing in the
pgWAT arise from a resident progenitor cell while the brite adipo-
cytes induced in the ingWAT appear to arise by transdifferentiation
[41,50]. This suggests that the mechanism by which brite adipocytes
arise varies with the depot and the duration of stimulation. Perhaps
immediate responding brite adipocytes exist in ingWAT but not in
pgWAT, which would explain why brite adipocytes only appear after
chronic cold exposure in pgWAT, but are often readily detectable in
ingWAT even at ambient temperature. The emerging nascent brite cell
population in pgWAT traces to a platelet-derived growth factor receptor
α (PDGFRα) positive precursor residing in the stromal vascular fraction
(labeled with an inducible PDGFRα-CreERT2 allele). This precursor pop-
ulation lacks expression of the cell surface markers CD24, PDGFRβ, the
endothelial marker IB4, and is negative for smooth muscle actin and
PPARγ, indicating it may be distinct from other precursors described
above [50,80,82]. Originally, it was reported that the fate of these
PDGFRα positive precursors is not restricted to brite fat because
high-fat diet feeding instructs them to become white adipocytes [50].
A more recent lineage tracing study using a constitutive PDGFRα-Cre
driver together with the R26R-mTmG reporter argues that all mature
adipocytes in allWAT depots are in fact derivatives of PDGFRα+precur-
sors [100]. Mature adipocytes do not express PDGFRα [50] indicating
these adipocytes are brandedwith PDGFRα-Cre as precursors.Whether
PDGFRα has a functional role in the adipocyte precursor is unclear.
However, PDGFR stimulation with ligand inhibits adipogenesis in
3T3-L1 cells [132] and expressing an activated mutant allele of PDGFRβ
in pericytes or mesenchymal progenitor cells blocks white adipocyte
differentiation [133], suggesting down-regulating PDGFR signaling
might be essential for adipocyte differentiation. More information
regarding PDGFR signaling can be found in [91].
A strong argument in favor of brite-to-white interconversion in
the ingWAT was recently reported [51]. In this study, researchers used
lineage tracing tomark the cold-induced brite adipocytes in the ingWAT
(with a UCP1-CreER driver) then followed their fate upon returning the
mice to warmer temperature. In response to warming (or “whitening”)
the brite adipocyte characteristics disappeared but importantly the adi-
pocytes that were labeled during cold-induced “brightening” retained
their lineage mark and now expressed “white” characteristics. This is
in contrast to classical brown adipocytes, which retain their brown char-
acteristics evenwhen unstimulated, and argues that brite adipocytes are
not dedifferentiated or eliminated when no longer needed. Moreover,
these same white adipocytes can be reconverted to brite adipocytes
upon subsequent cold challenge. Thus, in the ingWAT interconversion
between the white and brite state appears to be responsible for much
of the cold-induced changes in adipocyte morphology. Futures studies
are needed to determine whether depot, age, or strain speciﬁc differ-
ences exist in the interconversion rate and whether any lineages have
inherent potential to become brite when stimulated.
7. Ectopic adipocytes in skeletal muscle
Ectopic fat accumulation in muscle is a pathological feature of
several conditions including myopathies like Duchenne muscular
dystrophy (OMIM #310200), obesity, and type 2-diabetes [134,135].
Studies using FACS technology to prospectively isolate adipogenic
precursor cells from rodent limbmuscles are also beginning to expose
the identity of muscle resident adipogenic precursors [37,84,136].
While the cell surface marker proﬁles differ slightly between the dif-
ferent protocols (e.g. CD45−CD31−CD34+Sca1−α7-integrin− in [84]and CD31−CD45−SM/C-2.6− in [136]), almost all of the adipogenic
precursors identiﬁed in hind limb skeletal muscles express PDGFRα
[84,136]. These PDGFRα+ precursors are of mesenchymal origin and
reside in the interstitial space between muscle ﬁbers; however,
they are not marked with Myf5-Cre or Pax3-Cre by lineage tracing
and are distinct from satellite cells based on their localization
[84,124,136]. Muscle-resident adipogenic cells can also be isolated
using a CD45−Mac1−Sca1+ protocol [37]. In vitro, these cells can be
induced to express high levels of UCP1 when stimulated with bone
morphogenetic protein 7 (BMP7) suggesting they may function like
inducible brown adipocytes. In fact, a histological examination of
the thigh muscle revealed that brown adipocytes, deﬁned as UCP1-
positive multilocular cells, are interspersed in the muscle of mice
[137]. It is interesting that muscle-associated adipogenic precursors
originate from Myf5neg/Pax3neg lineages because this suggests that
the adipogenic cells in muscle may have migrated from a different
developmental location. It will be important to analyze the Myf5+/
Pax3+ lineage contribution to the muscle adipogenic precursor popu-
lations across several muscles to determine if the Myf5+ precursor
contribution varies with anatomical location.
8. What can we learn from our ancestors?
The ability to safely store large amounts of energy in adipocytes
was a critical adaptation in mammalian evolution. But as the energetic
cost of obtaining calories has plummeted compared to evolutionary
times, the remarkable energy storing capacity of adipose tissue is now
being revealed, as are its vices. White fat depots are dispersed through-
out the body, and while a typical healthy individual probably has
around 80,000 cal stored in fat (equivalent to over one month of
meals), the distribution of that fat between different depots is highly
variable in the population. These variations are exaggerated among
obese individuals. In general white adipose tissue biology is not well
understood, but perhaps one of the most clinically relevant mysteries
is why expansion of some depots (e.g. visceral white fat) correlates
with high risk of metabolic disease, while expansion of other depots
(e.g. subcutaneous white fat) is benign or protective. Although one rea-
son is likely that visceral depots drain directly into the liver causing
damage, there may be other underlying functional differences related
to origin. Likewhite fat, the amount of brown fat also varies between in-
dividuals and its presence negatively correlates with body mass index
[22,28,32,33]. The existence of brown fat cells in adult humans may
open doors to novel anti-obesity therapies that could function by in-
creasing brown fat energy expenditure; however, the study of human
brown fat is in its infancy.
Could lineage-tracing studies explain some of the variability
between fat depots? Previously it was thought that all adipocytes
descended from a common mesodermal precursor, but recent studies
have argued that this assumption is incorrect. A current trending
model is that brown, white, and brite adipocytes have distinct origins;
however, evidence is mounting that this view is too simplistic (Fig. 4).
Although all adipocytes have a common precursor if traced far
enough back, moving forward it will be important to determine
when unique adipocyte lineage marks are established and whether
early adipocyte ancestors convey unique properties to their descen-
dant adipocytes that make them functionally different from adipo-
cytes that arise from other lineages. Adipocyte lineages could vary
in their developmental gene expression pattern, which could affect
adipocyte metabolism, the regulatory circuits that control metabo-
lism or endocrine function, or the ability of resident progenitor cells
to respond to growth cues. Howmight this affect body fat patterning?
One possibility is that variations in metabolism or insulin sensitivity
between lineages could affect depot growth rate. Partial lipodystrophies
in which body fat is redistributed may be extreme examples of this.
Notably, the regional absence of fat tissue associated with many
lipodystrophies may often be caused by intrinsic loss of adipocyte
Fig. 4. A model based on recent lineage tracing studies that explains some of the complexity of adipocyte ancestry. A trending idea is that morphologically brown (multilocular),
white (unilocular), and brite (interconvertible) adipocytes develop along unique lineages. However, recent studies in mice using Cre–Lox technology to irreversibly label cellular
lineages argues that it is likely not this simple. An alternative view is that morphologically white adipocytes arise from multiple distinct lineages. One of these lineages is also
marked by ancestral Myf5 expression and gives rise to morphologically brown adipocytes, a subset of morphologically white adipocytes (e.g. in the asWAT and rWAT), skeletal
muscle cells, dermis, and ribs. Some of the Myf5-positive lineage derived white adipocytes become brite adipocytes when stimulated (e.g. Myf5-positive lineage white adipocytes
in rWAT and asWAT). Other markers such as Engrailed-1 might also express early in this lineage. Whether the Myf5 lineage derived brown and white adipocytes arise from the
same precursor is still unknown. Most white adipocytes in ingWAT and pgWAT develop from a Myf5-negative lineage (or possibly multiple lineages). Some of these
Myf5-negative lineage white adipocytes can also become brite when stimulated (e.g. the Myf5-negative lineage white adipocytes that undergo interconversion in the ingWAT).
Some brite adipocytes might also originate from a lineage distinct from the other white adipocytes although a Cre driver unique to a brite adipocyte lineage has not been found.
Although white/brite adipocyte lineages are just beginning to be deﬁned, PDGFRα appears to express in the ingWAT, pgWAT, rWAT, and mesenteric WAT lineages. Importantly,
when each lineage mark actually expresses, when the lineages diverge during development, and the earliest common mesenchymal progenitor cell remain unclear and this is
indicated by dotted lines and question marks. Another distinct white adipocyte lineage arises from Sox10 and Wnt1-expressing neural crest precursors in the cephalic region of
young mice (notably, an unidentiﬁed lineage begins replacing neural crest derived cephalic adipocytes with age). These adipocytes label positive for PDGFR-α+ by antibody staining
and therefore likely would trace with PDGFR-Cre, although this has not been shown. In sum, the emerging lineage tracing data presents a complex picture of adipocyte origins. iBA,
sBA, and cBA = interscapular, subscapular, and cervical brown adipocyte; asWA, rWA, pgWA, and ingWA = anterior subcutaneous, retroperitoneal, perigonadal, and inguinal
white adipocyte. For more detailed information see [50,51,83,100,103,114,116,127].
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is also possible, that is a subset of regionally overactive fat tissues can
prohibit the formation of fat depots in distal regions (Fig. 2). To what
extent adipocytes vary in their origin, and whether origin inﬂuences
function, remains to be seen. One thing that is clear is that different fat
depots are heterogeneous, and thus it seems prudent at this point to
view each depot as a unique organ when experimenting.
Is there an advantage to having adipocytes that arise from dif-
ferent developmental origins? One possibility is that having multiple
origins might ensure that fat tissue still grows if one lineage becomes
compromised (for example by a spontaneous mutation). Partial
lipodystrophy syndromes again are examples of this in which regional
lipoatrophy is often compensated for by lipohypertrophy of other
depots. A second possibility is that some adipose tissue depots may
grow in coordination with adjacent lean tissues, perhaps from a com-
mon precursor, to provide a locally available fuel reserve or other
support service. This suggests a fate switching mechanisms could exist
in a common precursor. Such a model has been proposed for brown
adipose tissue and skeletal muscle development [116]. Adipose tissues
of different origins could have other specialized functions, such ashormone production, responding to diet, or fueling exercise. In mice,
adipose tissues appear at different times during embryonic and
post-natal growth. Perhaps early growing fat depots arise as part of a
developmental program, and these are metabolically more favorable
depots. In contrast, the growth of less favorable fat tissues could arise
from different precursors later perhaps in close correlation with caloric
load. In mice for example, WATs that arise early such as subcutaneous
WATs tend to be more metabolically favorable, while pgWAT arises
later, is less vascularized, less innervated, and more static in response
to cold challenge [41,138].
What is the potential impact of understanding adipocyte origins
for human health? As coping with the consequences of extreme adi-
pose tissue growth is now a major burden on the health care system,
therapeutic methods to restore normal energy balance are in great
demand because exercise alone is no longer enough. Determining
where adipocytes originate is an essential step towards elucidating
the instructional program that functionally controls adipocyte devel-
opment and function, and elucidating these pathways may reveal
new mechanisms to block fat growth or increase the energy expendi-
ture. On the ﬂip side, adipose tissue is useful for reconstructive
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Adipose tissue is a source of adult stem/progenitor cells that are ob-
tainable by minimally invasive procedures, and there is clearly no
shortage of them. Understanding the origins of adipose stem cells
could be valuable in optimizing cell-based therapies. While the
mouse is invaluable for lineage-tracing studies because of its genetic
tractability, there are many differences between rodents and humans
with respect to fat distribution. Protocols to isolate human adipocyte
progenitor cells are under development and it will interesting and
important to determine which functional markers are conserved.
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